SCHEMBL25979581

SCHEMBL25979581

Cc1ccc(N2CCN(C(=O)N(Cc3ccc(C(=O)NO)cc3)c3ccc(C)cc3F)CC2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STAT3 P40763 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
KMT2A Q03164 3/20 0.44
CYP2C19 P33261 2/20 0.44
MEN1 O00255 2/20 0.44
HDAC6 Q9UBN7 6/20 0.44
HDAC8 Q9BY41 2/20 0.44
HDAC11 Q96DB2 1/20 0.44
MAPT P10636 6/20 0.43
ALDH1A1 P00352 3/20 0.43
CYP2C9 P11712 1/20 0.43
HPGD P15428 1/20 0.43
HDAC1 Q13547 3/20 0.41
LMNA P02545 3/20 0.41
KDM4E B2RXH2 1/20 0.41
GAA P10253 1/20 0.41
ALOX15 P16050 1/20 0.41
ALOX12 P18054 1/20 0.41
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16211605 0.96 MAPT (0.44) STAT3SMN1; SMN2KMT2ACYP2C19MEN1
SCHEMBL16211341 0.89 HDAC6 (0.47) STAT3KMT2AMEN1HDAC6HDAC8
SCHEMBL25980994 0.88 CETP (0.43) STAT3SMN1; SMN2KMT2ACYP2C19MEN1
SCHEMBL16211513 0.88 STAT3 (0.46) STAT3SMN1; SMN2HDAC6HDAC8HDAC11
SCHEMBL16211346 0.88 STAT3 (0.46) STAT3KMT2AMEN1HDAC6HDAC8
SCHEMBL16211628 0.88 HDAC6 (0.53) STAT3HDAC6HDAC8HDAC11HDAC1
SCHEMBL16211424 0.86 MAPT (0.48) SMN1; SMN2KMT2AMEN1MAPTALDH1A1
SCHEMBL25979678 0.84 MAPT (0.45) SMN1; SMN2KMT2ACYP2C19MEN1HDAC6
SCHEMBL16211643 0.84 DRD2 (0.49) SMN1; SMN2KMT2AMEN1MAPTALDH1A1
SCHEMBL22218776 0.82 ALDH1A1 (0.42) STAT3SMN1; SMN2KMT2ACYP2C19MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230248735-A1 COMPOSITIONS FOR PREVENTING OR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASES (COPD) CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2023-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230248735-A1 COMPOSITIONS FOR PREVENTING OR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASES (COPD) NR1H2, CFTR, CYP11B2 STAT3 3635/4885SMN1; SMN2 4332/4885KMT2A 4539/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.